NTT's deal to buy a large chunk of Intage (4326) is interesting, and the numbers may be confusing. Pro-ration estimates are tough. But not impossible. Then you think about the Other Risks.
Boomeranged on Sat, 23 Sep 2023 11:49
When I wrote this, 9 out of 11 cases presented, including my base case, had NAVF-held shares being tendered (whether they sell, or they tender). After I wrote, they sold from 12+ to 2%. The key now is your bet on Dai-Ichi Life, the ESOP, the other corps, retail, and the post-deal overhang. Will irrevocables sell remainders at a lower price? How long til a takeout tender? Do you like the back end?
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.